Pre-Made Choriogonadotropin Beta Biosimilar, Recombinant Protein targeting LHCGR: Recombinant therapeutic protein targeting HHG/LCGR/LGR2/LH/CG-R/LH/CGR/LHR/LHRHR/LSH-R/ULG5 for drug discovery and mechanism of action (MOA) research

Pre-Made Choriogonadotropin Beta Biosimilar, Recombinant Protein targeting LHCGR: Recombinant therapeutic protein targeting HHG/LCGR/LGR2/LH/CG-R/LH/CGR/LHR/LHRHR/LSH-R/ULG5 is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Choriogonadotropin subunit beta (CG-beta) also known as chorionic gonadotrophin chain beta. CG is produced by the trophoblastic cells of the placenta and stimulates the ovaries to synthesize the steroids that are essential for the maintenance of pregnancy.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-INN-778-1mg	1mg	3090
GMP-Bios-INN-778-10mg	10mg	Inquiry
GMP-Bios-INN-778-100mg	100mg	Inquiry
GMP-Bios-INN-778-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Choriogonadotropin Beta Biosimilar, Recombinant Protein targeting LHCGR: Recombinant therapeutic protein targeting HHG/LCGR/LGR2/LH/CG-R/LH/CGR/LHR/LHRHR/LSH-R/ULG5
INN Name	Choriogonadotropin Beta
Target	LHCGR
Format	Recombinant Protein
Derivation	human
Species Reactivity	human
CH1 Isotype	chorionic gonadotropin
VD LC	chorionic gonadotropin
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies	Ferring Pharmaceuticals (Saint-Prex Switzerland)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech	0